Nourianz

Product manufactured by Kyowa Kirin, Inc.

Application Nr Approved Date Route Status External Links
NDA022075 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Nourianz Is Indicated As Adjunctive Treatment To Levodopa/carbidopa In Adult Patients With Parkinson's Disease (Pd) Experiencing "off" Episodes. Nourianz Is An Adenosine Receptor Antagonist Indicated As Adjunctive Treatment To Levodopa/carbidopa In Adult Patients With Parkinson's Disease (Pd) Experiencing "off" Episodes ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Istradefylline ISTRADEFYLLINE ZINC3803921

Comments